Viewing Study NCT04739566


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2025-12-31 @ 5:07 AM
Study NCT ID: NCT04739566
Status: WITHDRAWN
Last Update Posted: 2024-03-25
First Post: 2021-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid Cancer
Sponsor: Saint Petersburg State University, Russia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module